C World Wide Group Holding A Insmed Inc Transaction History

C World Wide Group Holding A

$9.63 Billion
Q3 2024

A detailed history of C World Wide Group Holding A transactions in Insmed Inc stock. As of the latest transaction made, C World Wide Group Holding A holds 343,110 shares of INSM stock, worth $24.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

343,110

Previous 343,110 -0.0%

Holding current value

$24.2 Million

Previous $23 Million 8.96%

% of portfolio

0.26%

Previous 0.25%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$32.28 - $44.3 $1.29 Million - $1.77 Million	-40,000 Reduced 10.44%	343,110 $11.7 Million
Q4 2020 Feb 05, 2021	SELL	$31.45 - $40.54 $1.89 Million - $2.43 Million	-60,000 Reduced 13.54%	383,110 $12.8 Million
Q3 2019 Nov 04, 2019	BUY	$15.49 - $25.78 $774,500 - $1.29 Million	50,000 Added 12.72%	443,110 $7.82 Million
Q2 2019 Aug 02, 2019	BUY	$23.0 - $32.19 $6.44 Million - $9.01 Million	280,000 Added 247.55%	393,110 $10.1 Million
Q4 2018 Feb 12, 2019	SELL	$11.6 - $18.7 $1.48 Million - $2.38 Million	-127,532 Reduced 53.0%	113,110 $1.48 Million
Q3 2018 Nov 05, 2018	SELL	$18.95 - $28.08 $3.23 Million - $4.78 Million	-170,312 Reduced 41.44%	240,642 $4.87 Million
Q2 2018 Aug 03, 2018	BUY	$20.0 - $29.72 $765,840 - $1.14 Million	38,292 Added 10.28%	410,954 $9.72 Million
Q1 2018 May 03, 2018	SELL	$21.69 - $32.99 $419,593 - $638,191	-19,345 Reduced 4.93%	372,662 $8.39 Million
Q4 2017 Feb 07, 2018	SELL	$26.43 - $31.78 $1.46 Million - $1.76 Million	-55,422 Reduced 12.39%	392,007 $12.2 Million
Q3 2017 Nov 06, 2017	BUY	$11.61 - $31.21 $5.19 Million - $14 Million	447,429	447,429 $14 Million

Others Institutions Holding INSM

# of Institutions

466

Shares Held

180M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.56B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.

Account

C World Wide Group Holding A Insmed Inc Transaction History